FT Options’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
$146K Buy
17,500
+15,000
+600% +$125K 0.22% 47
2017
Q2
$42K Buy
+2,500
New +$42K 0.07% 51